atai Life Sciences (NASDAQ:ATAI, ETR:9VC), a clinical-stage biopharmaceutical company focused on mental health treatments, will participate in the TD Cowen 45th Annual Health Care Conference in Boston from March 3 to 5, 2025.
The company’s management will host a fireside chat on March 3 at 11:50 am Eastern Time, with a webcast available.
A replay will be accessible on atai’s website under Events for 90 days.